Sternal Closure Systems Market, By Product (PEEK (Poly-Ether-Ether-Ketone), Stainless Steel, Titanium Products, and Others), By Application (Bilateral Thoracosternotomy, Median Sternotomy, Hemisternotomy and Others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

Sternal Closure are rigid fixation device which are used for closing the sternum and breastbone. Sternal Closure are made up of biocompatible titanium alloy. Sternal Closures are available in single and double talon, single talon has a single foot plate on each side of sternum and double talon has two foot plates on each side of sternum. The sternum is closed with steel wires which are non-absorbable sutures. Sternal closures are used in paediatric cardiac surgeries. The wire used in open heart surgery are made up of titanium or stainless steel which are different cardiac devices. Sternal wires are used in surgical process to close the breastbone by following guidelines of surgical procedure on the heart. Then, the chest is closed by internal and external stitches. Median sternotomy are used in thoracic surgery for lower trachea, mediastinal and main stem bronchus surgery. Increase in surgical procedures has given rise to use of sternal closure system in market. The Global Sternal Closure Systems Market size accounted for US$ 2.3 billion in 2020 and is estimated to be US$ 3.79 billion by 2030 and is anticipated to register a CAGR of 5.6%.

Rise in cardiac surgeries and rate of urbanization

Rise in cardiac surgeries and increase in rate of urbanization is one of the leading factors for the for the Global Sternal Closure Systems Market growth. Demand for cardiac surgeries are increased due to rise in cardiovascular diseases. Urban culture affects the persons living lifestyle. Change in lifestyle has driven the unhealthy dietary habits, high incidence of alcohol use and smoking, atherogenic dyslipidaemia, sedentary lifestyle, lack of exercise has become largely contributory in rise of cardiac diseases. However, due to better medical facilities in metro urban cities cardiac surgeries are highly performed. According to data published by United Nations in 2014, about 54% of the world’s population resided in urban areas, and it is projected that this percentage will increase over the forecast period. However, the growth in cardiac diseases in urban areas boosts the demand for Sternal Closure Systems Market.

                                                           Technological advancement

Manufactures involved in sternal closure systems market are developing advanced versions of their products due to new age technological advancements. Newly technological advancements in cardiac surgical procedures has given rise in sternal closure system market. Availability of newer techniques like DES, OP CAB, TECAB, MIDCAB are bound to improve short & long term results. For instance, in 2013 (NIH), use of titanium hooks in sternal closure system which inserted parasternally was effective to conventional techniques and helps in reducing the risk of injury to restrosternal tissues and also increase the stability of the breastbone.

Restrains:

However, infection risks and costly surgical procedures may somewhat restrain the growth of the target market.

Sternal Closure Systems Market is segmented based on product, application, and region.

On the basis of product, the Sternal Closure Systems Market is segmented into, PEEK (Poly-Ether-Ether-Ketone), Stainless Steel, Titanium Products, and others. On the basis of application, the target market is classified into Bilateral Thoracosternotomy, Median Sternotomy, Hemisternotomy and others.

Regional Insights:

On region the Sternal Closure Systems Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period, owing to growing population, and owing to increase in number of heart surgeries and technological advancements. Moreover, rising of cardiovascular surgeries is anticipated to increase demand for Sternal Closure Systems in the region.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the Global Sternal Closure Systems Market report based on product, application, and region:

Sternal Closure Systems Market, By Product:

• PEEK (Poly-Ether-Ether-Ketone)
• Stainless Steel
• Titanium Products
• Others

Sternal Closure Systems Market, By Application:

• Bilateral Thoracosternotomy
• Median Sternotomy
• Hemisternotomy
• Others

Sternal Closure Systems Market, By Region:

• North America
  • Middle East & Africa
    • • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • • U.S.
    • Canada

The key players operating the Sternal Closure Systems Market includes, Kinamed Incorporated, Immunogen Inc., Seattle Genetics Inc., A&E Medical, Orthofix Holdings Inc., Takeda Pharmaceutical Company Limited, Zimmer Biomet Holdings Inc., Depuy Synthes, Pfizer Inc., Acute Innovations, KLS Martin Group, Hoffman-La Roche Ltd., Bayer Healthcare Pharmaceuticals, Novartis AG, etc. Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market. For instance, in 2020, Zimmer Biomet Holdings Inc., boosts the portfolio with A&E medical buyont and completed the acquisition of Vance Street Capital portfolio company, A&E Medical for total value of transaction around $250 million. Thus, Zimmer Biomet Holdings Inc., determines the global sternal closure system market to grow at high single-digit percentage and target the fast expansion in sternal closure devices in the market.

• Zimmer Biomet Holdings Inc.*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Kinamed Incorporated
• Immunogen Inc.
• Seattle Genetics Inc.
• A&E Medical
• Orthofix Holdings Inc.
• Takeda Pharmaceutical Company Limited
• Depuy Synthes
• Pfizer Inc.
• Acute Innovations
• KLS Martin Group
• Hoffman-La Roche Ltd.
• Bayer Healthcare Pharmaceuticals
• Novartis AG

 “*” marked represents similar segmentation in other categories in the respective section